Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome

Clinical Science

Volumn 114, Issue 3-4, 2008, Pages 183-193

  Aguilera, Concepción M ^a   Gil Campos, Mercedes ^b   Cañete, Ramón ^b   Gil, Ángel ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

AMP dependent kinase (AMPK); Fatty acid oxidation; Hypothalamus; Lipid; Metabolic syndrome; Non esterified fatty acid (NEFA); Obesity

Indexed keywords

ADENYLATE KINASE; ADIPOCYTOKINE; APOLIPOPROTEIN B; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LIPID; LIPID EMULSION; LONG CHAIN FATTY ACID COENZYME A LIGASE; LOW DENSITY LIPOPROTEIN; MALONYL COENZYME A; MONOUNSATURATED FATTY ACID; OLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN KINASE C; TRIACYLGLYCEROL LIPASE; TRICHLOROETHYLENE; LIPOPROTEIN;

ADIPOSE TISSUE; BLOOD CHEMISTRY; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; EXPERIMENTAL MOUSE; FATTY ACID OXIDATION; GENETIC ASSOCIATION; GLUCOSE INTOLERANCE; HORMONAL REGULATION; HUMAN; HYPERLEPTINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTHALAMUS; INSULIN RESISTANCE; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID METABOLISM; LIPID STORAGE; LIVER; METABOLIC SYNDROME X; MUSCLE TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT AVAILABILITY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; BLOOD; METABOLISM; OXIDATION REDUCTION REACTION;

FATTY ACIDS; HUMANS; HYPOTHALAMUS; LIPID METABOLISM; LIPOPROTEINS; METABOLIC SYNDROME X; OBESITY; OXIDATION-REDUCTION;

EID: 38949161289     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070115     Document Type: Review

References (92)

1. Gil-Hernández, A. (2002) Obesidad y genes. Vox. Paediatrica 10, 40-45
2. Astrup, A., Buemann, B., Christensen, N. J. and Toubro, S. (1994) Failure to increase lipid oxidation in response to increasing dietary fat content in formerly obese women. Am. J. Physiol. 266, E592-E599
3. Filozof, C. M., Murua, C., Sánchez, M. P. et al. (2000) Low plasma leptin concentration and low rates of fat oxidation in weight-stable post-obese subjects. Obes. Res. 8, 205-210
4. Sampath, H. and Ntambi, J. M. (2006) Stearoyl-coenzyme A desaturase 1, sterol regulatory element binding protein-1ic and peroxisome proliferator-activated receptor-α: independent and interactive roles in the regulation of lipid metabolism. Curr. Opin. Clin. Nutr. Metab. Care 9, 84-88
5. Rankinen, T., Zuberi, A., Chagnon, Y. C. et al. (2006) The human obesity gene map: the 2005 update. Obes. Res. 14, 529-644
6. Reaven, G. M. (1995) Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75, 473-486
7. Smith, J., Al-Amri, M., Dorairaj, P. and Sniderman, A. (2006) The adipocyte life cycle hypothesis. Clin. Sci. 110, 1-9
8. Reaven, G. M. (2005) The insulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr. 25, 391-406
9. Alberti, K., Zimmet, P. and Consultation, W. (1998) Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabetic Med. 15, 539-553
10. Weiss, R., Dufour, S., Taksali, S. et al. (2003) Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 362, 951-957
11. Haslam, D. W. and James, W. P. T. (2005) Obesity. Lancet 366, 1197-1209
12. Reinehr, T., Holl, R. W., Roth, C. L. et al. (2005) Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity. Pediatr. Diabetes 6, 3-4
13. Goldstein, B. J. (2002) Insulin resistance as the core defect in type 2 diabetes mellitus. Am. J. Cardiol. 90, (Suppl.), 3G-10G
14. Kopelman, P. G. (2000) Obesity as a medical problem. Nature 404, 635-643
15. Valle, M., Gascón, F., Martos, R., Bermudo, F., De Torres, G. and Cañete, R. (1999) Apolipoproteins in the obese child: Correlation with antropometric measures and insulin levels. Clin. Chem. Lab. Med. 37, 276
16. Valle, M., Gascón, F., Martos, R. et al. (2000) Infantile obesity: A situation of atherothrombotic risk? Metab. Clin. Exp. 49, 672-675
17. Valle, M., Gascón, F., Martos, R., Ruiz, F., Ríos, R. and Cañete, R. (2001) Apo A-I decrease and tryglicerides increase serum levels in hiperinsulinemic children. Clin. Chem. Lab. Med. 39, 247
18. Brunzell, J. D. and Hokanson, J. E. (1999) Low-density and high-density lipoprotein subspecies and risk for premature coronary artery disease. Am. J. Med. 107, 16S-18S
19. Belfort, R., Mandarino, L., Kashyap, S. et al. (2005) Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54, 1640-1648
20. Zammit, V. A., Waterman, I. J., Topping, D. and McKay, G. (2001) Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J. Nutr. 131, 2074-2077
21. Gil-Campos, M., Cañete, R. and Gil, A. (2004) Hormones regulating lipid metabolism and plasma lipids in childhood obesity. Int. J. Obes. Relat. Metab. Disord. 3, S75-S80
22. Jensen, M. D. (1997) Health consequences of fat distribution. Horm. Res. 48, 88-92
23. Sprangers, F., Romijn, J. A., Endert, E., Ackermans, M. T. and Sauerwein, H. P. (2001) The role of free fatty acids (FFA) in the regulation of intrahepatic fluxes of glucose and glycogen metabolism during short-term starvation in healthy volunteers. Clin. Nutr. 20, 177-179
24. Bergman, R. N. and Ader, M. (2000) Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab. 11, 351-356
25. Marsh, J. B. (2003) Lipoprotein metabolism in obesity and diabetes: insights from stable isotope kinetic studies in humans. Nutr. Rev. 61, 363-375
26. Chen, X., Iqbal, N. and Boden, G. (1999) The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J. Clin. Invest. 103, 365-372
27. Grundy, S. M., Cleeman, J. I., Daniels, S. R. et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735-2752
28. Syvanne, M. and Taskinen, M. R. (1997) Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 350, SI20-SI23
29. Chan, D. C., Watts, G. F., Redgrave, T. G., Mori, T. A. and Barrett, P. H. (2002) Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. Metab. Clin. Exp. 51, 1041-1046
30. Stancakova, A., Baldaufova, L., Javorsky, M., Kozarova, M., Salagovic, J. and Tkac, I. (2006) Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome. Physiol. Res. 55, 483-490
31. Wajchenberg, B. L. (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21, 697-738
32. Bergman, R. N., Kim, S. P., Hsu, I. R. et al. (2007) Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am. J. Med. 120, 3-8
33. Grill, V. and Qvigstad, E. (2000) Fatty acids and insulin secretion. Br. J. Nutr. 83, 79-84
34. Kohen-Avramoglu, R., Theriault, A. and Adeli, K. (2003) Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia. Clin. Biochem. 36, 413-420
35. Belfort, R., Mandarino, L., Kashyap, S. et al. (2005) Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54, 1640-1648
36. Ruderman, N. B., Saha, A. K. and Kraegen, E. W. (2003) Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144, 5166-5171
37. Ruderman, N. B., Saha, A. K., Vavvas, D., Heydrick, S. J. and Kurowski, T. G. (1997) Lipid abnormalities in muscle of insulin-resistant rodents. The malonyl CoA hypothesis. Ann. N.Y. Acad. Sci. 827, 221-230
38. Nolan, C. J., Madiraju, M. S., Delghingaro-Augusto, V., Peyot, M. L. and Prentki, M. (2006) Fatty acid signaling in the β-cell and insulin secretion. Diabetes 55, 16-23
39. Hosokawa, H., Corkey, B. E. and Leahy, J. L. (1997) β-Cell hypersensitivity to glucose following 24-h exposure of rat islets to fatty acids. Diabetologia 40, 392-397
40. Shimabukuro, M., Zhou, Y. T., Levi, M. and Unger, R. H. (1998) Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. U.S.A. 95, 2498-2502
41. Kahn, S., Prigeon, R., Schwartz, R. et al. (2001) Obesity, body fat distribution, insulin sensitivity and islet β-cell function as explanations for metabolic diversity. J. Nutr. 131, 354-360
42. Rossner, S., Walldius, G. and Bjorvell, H. (1989) Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. Int. J. Obes. 13, 603-612
43. Phinney, S. D., Tang, A. B., Thurmond, D. C., Nakamura, M. T. and Stern, J. S. (1993) Abnormal polyunsaturated lipid metabolism in the obese Zucker rat, with partial metabolic correction by gamma-linolenic acid administration. Metab. Clin. Exp. 42, 1127-1140
44. Phinney, S. D., Fisler, J. S., Tang, A. B. and Warden, C. (1994) Liver fatty acid composition correlates with body fat and gender in a multigenic mouse model of obesity. Am. J. Clin. Nutr. 60, 61-67
45. Kunesova, M., Hainer, V., Tvrzicka, E. et al. (2002) Serum and adipose tissue fatty acid composition in female obese identical twins. Lipids 37, 27-32
46. Vessby, B. (2003) Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol. 14, 15-19
47. Tremblay, A. J., Despres, J. P., Piche, M. E. et al. (2004) Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. Metab. Clin. Exp. 53, 310-317
48. Klein-Platat, K., Drai, J., Oujaa, M., Schlienger, J. L. and Simon, C (2005) Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am. J. Clin. Nutr. 82, 1178-1184
49. Phinney, S. D. (2005) Fatty acids, inflammation and metabolic syndrome. Am. J. Clin. Nutr. 82, 1151-1152
50. Garaulet, M., Pérez-Llamas, F. and Pérez-Ayala, M. (2001) Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. Am. J. Clin. Nutr. 74, 585-591
51. Warensjo, E., Riserus, U. and Vessby, B. (2005) Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 48, 1999-2005
52. Cañete, R., Gil-Campos, M., Aguilera, C. M. and Gil, A. (2007) Development of insulin resistance and its relation to diet in the obese child. Eur. J. Nutr. 46, 181-187
53. Simopoulus, A. P. (1994) Is insulin resistance influenced by dietary linoleic acid and trans fatty acids? Free Radical Biol. Med. 17, 367-372
54. McAuley, K. A. and Mann, J. L. (2006) Nutritional determinants of insulin resistance. J. Lipid Res. 47, 1668-1676
55. Ravussin, E. and Smith, S. R. (2002) Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann. N.Y. Acad. Sci. 967, 363-378
56. Unger, R. H. and Orci, L. (2001) Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 15, 312-321
57. Baile, C. A., Della-Fera, M. A. and Martin, R. J. (2000) Regulation of metabolism and body fat mass by leptin. Annu. Rev. Nutr. 20, 105-127
58. Friedman, J. M. (1998) Leptin, leptin receptors, and the control of body weight. Nutr. Rev. 56, 38-46
59. Neel, J. V., Weder, A. B. and Julius, S. (1998) Type II diabetes, essential hypertension, and obesity as 'syndromes of impaired genetic homeostasis': the 'thrifty genotype' hypothesis enters the 21st century. Perspect. Biol. Med. 42, 44-74
60. Lee, Y., Wang, M. Y. and Kakuma, T. (2001) Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J. Biol. Chem. 276, 5629-5635
61. Steinberg, G. R., Parolin, M. L., Heigenhauser, G. J. and Dyck, D. J. (2002) Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am. J. Physiol. Endocrinol. Metab. 283, E187-E192
62. Unger, R. H. (2003) The physiology of cellular liporegulation. Annu. Rev. Physiol. 65, 333-347
63. Unger, R. H. (2005) Hyperleptinemia: protecting the heart from lipid overload. Hypertension 45, 1031-1034
64. Oral, E. A., Ruiz, E. and Andewelt, A. (2002) Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. J. Clin. Endocrinol. Metab. 87, 3110-3117
65. Javor, E. D., Cochran, E. K., Musso, C., Young, J. R., Depaoli, A. M. and Gorden, P. (2005) Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 54, 1994-2002
66. Cañete, R., Gil, M. and Poyato, J. L. (2003) Obesidad en el niño: nuevos conceptos de etiopatogenia y tratamiento. Pediatr. Integral. 7, 480-490
67. Groop, L. (2000) Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion. Int. J. Clin. Pract. 113, 3-13
68. Minokoshi, Y. and Kahn, B. B. (2003) Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. Biochem. Soc. Trans. 31, 196-201
69. Andersson, U., Filipsson, K., Abbott, C. R. et al. (2004) AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279, 1205-1208
70. Minokoshi, Y., Alquier, T., Furukawa, N. et al. (2004) AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569-574
71. Gil-Campos, M., Cañete, R. and Gil, A. (2004) Adiponectin, the missing link in insulin resistance and obesity. Clin. Nutr. 23, 963-974
72. Beltowski, J. (2003) Adiponectin and resistin: new hormones of white adipose tissue. Med. Sci. Monit. 9, RA55-RA61
73. Stefan, N. and Stumvoll, M. (2002) Adiponectin: its role in metabolism and beyond. Horm. Metab. Res. 34, 469-474
74. Arita, Y., Kihara, S., Ouchi, N. et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79-83
75. Diez, J. J. and Iglesias, P. (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol. 148, 293-300
76. Stefan, N., Vozarova, B., Funahashi, T. et al. (2002) Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51, 1884-1888
77. Yamauchi, T., Kamon, J., Minokoshi, Y. et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295
78. Maeda, N., Shimomura, I., Kishida, K. et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8, 731-737
79. Yamauchi, T., Kamon, J., Ito, Y. et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769
80. Erratum (2004) Nature 431, 1123
81. Fruebis, J., Tsao, T. S., Javorschi, S. et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U.S.A. 98, 2005-2010
82. Lam, T. K., Schwartz, G. J. and Rossetti, L. (2005) Hypothalamic sensing of fatty acids. Nat. Neurosci. 8, 579-584
83. Woods, S. C., Stein, L. J., McKay, L. D. and Porte, Jr, D. (1984) Suppression of food intake by intravenous nutrients and insulin in the baboon. Am. J. Physiol. 247, R393-R401
84. Obici, S., Feng, Z., Karkanias, G., Baskin, D. G. and Rossetti, L. (2002) Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat. Neurosci. 5, 566-572
85. Morgan, K., Obici, S. and Rossetti, L. (2004) Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J. Biol. Chem. 279, 3139-3148
86. Obici, S., Feng, Z., Morgan, K., Stein, D., Karkanias, G. and Rossetti, L. (2002) Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51, 271-275
87. Lam, T. K., Pocai, A. and Gutierrez-Juárez, R. (2005) Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat. Med. 11, 320-327
88. Obici, S., Feng, Z., Arduini, A., Conti, R. and Rossetti, L. (2003) Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat. Med. 9, 756-761
89. Kim, E. K., Miller, I., Landree, L. E. et al. (2002) Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. Am. J. Physiol. Endocrinol. Metab. 283, E867-E879
90. Clegg, D. J., Wortman, M. D., Benoit, S. C., McOsker, C. C. and Seeley, R. J. (2002) Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion. Diabetes 51, 3196-3201
91. Makimura, H., Mizuno, T. M., Yang, X. J., Silverstein, J., Beasley, J. and Mobbs, C. V. (2001) Cerulenin mimics effects of leptin on metabolic rate, food intake, and body weight independent of the melanocortin system, but unlike leptin, cerulenin fails to block neuroendocrine effects of fasting. Diabetes 50, 733-739
92. Loftus, T. M., Jaworsky, D. E. and Frehywot, G. L. (2000) Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379-2381